Recent reviews by the Institute of Medicine and the National Cancer Institute concluded that low yield cigarettes have not been demonstrated to reduce disease risks in smokers who use them. The original public health recommendations that low yield cigarettes could reduce risks underestimated smokers ability to compensate for reduced nicotine delivery by smoking more intensely. These recommendations also underestimated the ability of the tobacco companies to design cigarettes that delivered very low levels of tar on machine measurement while delivering much higher levels of tar to smokers when they compensated. Among the lessons learned are that reductions in risk must be based on exposure measurements made on populations of smokers actually using new products and that harm estimation must include impacts on smoking cessation rates as well as measures of toxicity and disease outcome.
Learning Objectives: See session objectives
Keywords: Tobacco Control, Tobacco
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.